Great News! IVRS and Succipro Secure Eurostars Funding to Advance Next-Generation Treatment for Crohn’s Disease
We’re proud to share that IVRS AB and Succipro S.L. have received Eurostars funding to develop a new biologic therapy for Crohn’s disease, an important step toward more precise and effective treatments for inflammatory bowel disease (IBD). This collaboration brings together Succipro’s expertise in biologic drug development and IVRS’s advanced in vivo imaging capabilities, creating […]
IVRS is honored to receive the Branschvinnare i Sverige AB award for our dedication to excellence in the industry
We proudly announce that IVRS AB has been appointed to Industry Winner 2024 within Biotechnical Research and Development! Branschvinnare i Sverige AB awards this title to companies that have surpassed industry standards in both revenue and results. In 2024, only 14% of companies in Sweden are awarded this title. Visit our website to find out […]
